Tempus Trans

Tempus Trans company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are Tempus Trans, a group of companies that specialize in providing shipment services for both less than truck and full truck loads for more than 18 years. Our services include: - Parcel delivery - Less than truckload shipments - Full truckload shipments - Temperature-controlled load shipments - Shipment of dangerous goods (ADR) - Express load shipments We provide our services across North-Eastern Europe, the Balkans, the Caucasus, and Central Asia. With 4 international headquarters, 1000+ happy customers, and 200000+ shipments, we strive to deliver superior quality, speed, and efficiency to enhance the added value for both you and your customers. 📩 If you're interested in our services, reach us via email: info@tempus.lt

Company Details

Employees
42
Founded
-
Address
Naugarduko G. 99, Vilnius,03142,lithuania
Industry
Transportation, Logistics, Supply Chain And Storage
NAICS
Transportation and Warehousing
Support Activities for Transportation
Support Activities for Air Transportation
Support Activities for Rail Transportation
Support Activities for Water Transportation
Support Activities for Road Transportation
Freight Transportation Arrangement
Other Support Activities for Transportation
Airport Operations
Other Support Activities for Air Transportation
Port and Harbor Operations
Marine Cargo Handling
Navigational Services to Shipping
Other Support Activities for Water Transportation
Motor Vehicle Towing
Other Support Activities for Road Transportation
Air Traffic Control
Other Airport Operations
Packing and Crating
All Other Support Activities for Transportation
Website
tempus.lt
HQ
Vilnius
Looking for a particular Tempus Trans employee's phone or email?

Tempus Trans Questions

News

Tempus AI - Built In Chicago

Tempus AI Built In Chicago

Tempus inks $81M Paige buyout to support AI model development - MedTech Dive

Tempus inks $81M Paige buyout to support AI model development MedTech Dive

Press Release Service: Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform - CRISPR Medicine News

Press Release Service: Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform CRISPR Medicine News

Tempus claims AI pathology developer Paige in $81M deal - Fierce Biotech

Tempus claims AI pathology developer Paige in $81M deal Fierce Biotech

Why Tempus AI Stock Soared Nearly 14% Higher Today - The Motley Fool

Why Tempus AI Stock Soared Nearly 14% Higher Today The Motley Fool

AstraZeneca enters $200m AI cancer pact with Tempus and Pathos - Pharmaceutical Technology

AstraZeneca enters $200m AI cancer pact with Tempus and Pathos Pharmaceutical Technology

Tempus AI: High-Growth And High-Risk (NASDAQ:TEM) - Seeking Alpha

Tempus AI: High-Growth And High-Risk (NASDAQ:TEM) Seeking Alpha

Why It Might Be Time To Take Profits In This Top 8% Medtech - Investor's Business Daily

Why It Might Be Time To Take Profits In This Top 8% Medtech Investor's Business Daily

Tempus AI: TEM Stock To $400? - Forbes

Tempus AI: TEM Stock To $400? Forbes

THE TEMPUS IS HERE - Slowtwitch News

THE TEMPUS IS HERE Slowtwitch News

Tempus AI hits back at scathing short report - TheStreet

Tempus AI hits back at scathing short report TheStreet

Why Does Nancy Pelosi Like Tempus AI (TEM) Stock So Much? - Yahoo Finance

Why Does Nancy Pelosi Like Tempus AI (TEM) Stock So Much? Yahoo Finance

Tempus Reports First Quarter 2025 Results - Business Wire

Tempus Reports First Quarter 2025 Results Business Wire

Tempus AI in line for $200M from AstraZeneca, Pathos deal to develop cancer model - Fierce Biotech

Tempus AI in line for $200M from AstraZeneca, Pathos deal to develop cancer model Fierce Biotech

Why Artificial Intelligence Stock Tempus AI Is Tumbling Today - The Motley Fool

Why Artificial Intelligence Stock Tempus AI Is Tumbling Today The Motley Fool

Tempus AI: Wait For A Cooldown (NASDAQ:TEM) - Seeking Alpha

Tempus AI: Wait For A Cooldown (NASDAQ:TEM) Seeking Alpha

Tempus Announces Acquisition of Deep 6 AI - Business Wire

Tempus Announces Acquisition of Deep 6 AI Business Wire

Tempus Completes Acquisition of Ambry Genetics - Business Wire

Tempus Completes Acquisition of Ambry Genetics Business Wire

Ares Management Upsizes Tempus Debt Facilities to $560 Million - Business Wire

Ares Management Upsizes Tempus Debt Facilities to $560 Million Business Wire

Finally, stability meets speed with the Saucony Tempus 2 - Runner's World

Finally, stability meets speed with the Saucony Tempus 2 Runner's World

Saucony Tempus 2 Review: Stability Racing Shoe - RunToTheFinish

Saucony Tempus 2 Review: Stability Racing Shoe RunToTheFinish

Tempus AI to buy genetic testing company for $600M - MedTech Dive

Tempus AI to buy genetic testing company for $600M MedTech Dive

The Tempus, Northumberland hotel review - The Independent

The Tempus, Northumberland hotel review The Independent

Tempus and Northwestern Medicine Announce Collaboration to Bring Practical Application of AI to Healthcare - Northwestern Medicine Newsroom

Tempus and Northwestern Medicine Announce Collaboration to Bring Practical Application of AI to Healthcare Northwestern Medicine Newsroom

Tempus AI acquires Paige for $81M - Mobi Health News

Tempus AI acquires Paige for $81M Mobi Health News

Tempus Reports Second Quarter 2025 Results - Yahoo Finance

Tempus Reports Second Quarter 2025 Results Yahoo Finance

What's Fueling Tempus AI's Explosive Sales Growth? - Yahoo Finance

What's Fueling Tempus AI's Explosive Sales Growth? Yahoo Finance

Illumina, Tempus AI partner to drive genomic testing beyond cancer - MedTech Dive

Illumina, Tempus AI partner to drive genomic testing beyond cancer MedTech Dive

Tempus to Report Third Quarter 2025 Financial Results on November 4 - Business Wire

Tempus to Report Third Quarter 2025 Financial Results on November 4 Business Wire

Tempus AI Surges Since IPO as FDA Clearance Boosts Growth Outlook - Yahoo Finance

Tempus AI Surges Since IPO as FDA Clearance Boosts Growth Outlook Yahoo Finance

Tempus AI Workers in Chicago Vote to Join IAM Union - IAM Union

Tempus AI Workers in Chicago Vote to Join IAM Union IAM Union

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research - Business Wire

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research Business Wire

Precision medicine company Tempus AI aims to raise $400M in IPO - Fierce Healthcare

Precision medicine company Tempus AI aims to raise $400M in IPO Fierce Healthcare

How To Tame The Tempest Of A Volatile Stock - Investor's Business Daily

How To Tame The Tempest Of A Volatile Stock Investor's Business Daily

Tempus AI Stock Scores Relative Strength Rating Upgrade - Investor's Business Daily

Tempus AI Stock Scores Relative Strength Rating Upgrade Investor's Business Daily

Introducing Tempus One in the EHR with Integrated Guidelines - Business Wire

Introducing Tempus One in the EHR with Integrated Guidelines Business Wire

Tempus unveils AI-enabled personal health concierge app - Mobi Health News

Tempus unveils AI-enabled personal health concierge app Mobi Health News

Why Tempus AI Stock Was Motoring Higher This Week - The Motley Fool

Why Tempus AI Stock Was Motoring Higher This Week The Motley Fool

Why Tempus AI Stock Soared 15.2% in June - The Motley Fool

Why Tempus AI Stock Soared 15.2% in June The Motley Fool

Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment - Business Wire

Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment Business Wire

Tempus AI: Strategic AI Advancements In Precision Oncology With Solid Stock Upside Potential - Seeking Alpha

Tempus AI: Strategic AI Advancements In Precision Oncology With Solid Stock Upside Potential Seeking Alpha

Tempus AI: Next Leg Up (NASDAQ:TEM) - Seeking Alpha

Tempus AI: Next Leg Up (NASDAQ:TEM) Seeking Alpha

Saucony Tempus 2 Review - Road Trail Run

Saucony Tempus 2 Review Road Trail Run

Tempus AI shares jump 9% in stock market debut as IPO priced at over $6B valuation - Fierce Healthcare

Tempus AI shares jump 9% in stock market debut as IPO priced at over $6B valuation Fierce Healthcare

Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut - CNBC

Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut CNBC

Why Tempus AI Stock Plummeted This Week - The Motley Fool

Why Tempus AI Stock Plummeted This Week The Motley Fool

Tempus AI Stock Soars to All-Time High - Investopedia

Tempus AI Stock Soars to All-Time High Investopedia

Forget AI? How Epic, Tempus AI And Doximity Use Network Effects In Healthcare - Forbes

Forget AI? How Epic, Tempus AI And Doximity Use Network Effects In Healthcare Forbes

Wall Street analysts bullish on genetic testing firm Tempus AI - Reuters

Wall Street analysts bullish on genetic testing firm Tempus AI Reuters

Pfizer, Tempus collaborate on cancer drug development - Mobi Health News

Pfizer, Tempus collaborate on cancer drug development Mobi Health News

Tempus AI: The Investment Opportunity Of A Decade, Strong Buy (NASDAQ:TEM) - Seeking Alpha

Tempus AI: The Investment Opportunity Of A Decade, Strong Buy (NASDAQ:TEM) Seeking Alpha

A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today - The Motley Fool

A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today The Motley Fool

SoftBank Group launches AI healthcare joint venture with Tempus AI - Reuters

SoftBank Group launches AI healthcare joint venture with Tempus AI Reuters

With Arterys acquisition under its belt, Tempus eyes big opportunities in medical imaging AI - Fierce Healthcare

With Arterys acquisition under its belt, Tempus eyes big opportunities in medical imaging AI Fierce Healthcare

SoftBank forms AI healthcare JV in Japan with Tempus - TechCrunch

SoftBank forms AI healthcare JV in Japan with Tempus TechCrunch

Tempus Raises $275M To Combat Three Of Drugmaking’s Biggest Challenges - Crunchbase News

Tempus Raises $275M To Combat Three Of Drugmaking’s Biggest Challenges Crunchbase News

Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time. - The Motley Fool

Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time. The Motley Fool

Tempus AI: Healthcare AI Play Faces Some Challenges From The Start (NASDAQ:TEM) - Seeking Alpha

Tempus AI: Healthcare AI Play Faces Some Challenges From The Start (NASDAQ:TEM) Seeking Alpha

Tempus AI Reverses 192% Run. Why At Least One Analyst Remains A Believer. - Investor's Business Daily

Tempus AI Reverses 192% Run. Why At Least One Analyst Remains A Believer. Investor's Business Daily

Veteran analyst unveils bold price target for Tempus AI stock - TheStreet

Veteran analyst unveils bold price target for Tempus AI stock TheStreet

Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI - TechCrunch

Tempus rises 9% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI TechCrunch

Saucony Tempus 2 Review - GearLab

Saucony Tempus 2 Review GearLab

GSK decides time is right to pay Tempus $70M to expand access to patient data library - Fierce Biotech

GSK decides time is right to pay Tempus $70M to expand access to patient data library Fierce Biotech

Tempus Ex rebrands as Infinite Athlete, acquires Biocore to create ‘OS for sport’ - SportsPro

Tempus Ex rebrands as Infinite Athlete, acquires Biocore to create ‘OS for sport’ SportsPro

Saucony Tempus Review: Stable Through the Storm - Believe in the Run

Saucony Tempus Review: Stable Through the Storm Believe in the Run

16. Tempus - CNBC

16. Tempus CNBC

Tempus Fugit Yacht - SuperYacht Times

Tempus Fugit Yacht SuperYacht Times

Tempus AI Careers, Perks + Culture - Built In

Tempus AI Careers, Perks + Culture Built In

Is the Saucony Tempus the Future of Stability Shoes? - Outside Magazine

Is the Saucony Tempus the Future of Stability Shoes? Outside Magazine

PNC Bank Announces Definitive Agreement To Acquire Tempus Technologies, Inc. - PR Newswire

PNC Bank Announces Definitive Agreement To Acquire Tempus Technologies, Inc. PR Newswire

Times Fly Running in Saucony’s New Stability Trainer: The Tempus - Runner's World

Times Fly Running in Saucony’s New Stability Trainer: The Tempus Runner's World

Best MW3 Tempus Razorback loadout and class setup - Rock Paper Shotgun

Best MW3 Tempus Razorback loadout and class setup Rock Paper Shotgun

Saucony Tempus Multi Tester Review: A Versatile, Support Daily Training Ride for all Runner Types! 18 Comparisons - Road Trail Run

Saucony Tempus Multi Tester Review: A Versatile, Support Daily Training Ride for all Runner Types! 18 Comparisons Road Trail Run

Tempus omnia revelat - Nature

Tempus omnia revelat Nature

Tempus Pro makes battlefield medical assistance as easy as Skype - marines.mil

Tempus Pro makes battlefield medical assistance as easy as Skype marines.mil

‘Sleepy Hollow’ recap: ‘Tempus Fugit’ - Los Angeles Times

‘Sleepy Hollow’ recap: ‘Tempus Fugit’ Los Angeles Times

News - Tempus Pro makes battlefield medical assistance as easy as Skype - DVIDS

News - Tempus Pro makes battlefield medical assistance as easy as Skype DVIDS

Top Tempus Trans Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant